These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 20049522

  • 1. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL, Hart CW.
    AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
    [Abstract] [Full Text] [Related]

  • 2. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH, Blanchard K, Chaikummao S, Friedland BA, Srivirojana N, Connolly C, Witwatwongwana P, Supawitkul S, Mock PA, Chaowanachan T, Tappero J.
    Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
    [Abstract] [Full Text] [Related]

  • 3. Challenges of introducing vaginal microbicides in India.
    Joshi S, Kulkarni V, Paranjape R, Chandhiok N.
    Indian J Med Res; 2009 May; 129(5):618-9. PubMed ID: 19675395
    [No Abstract] [Full Text] [Related]

  • 4. Specific microbicides in the prevention of HIV infection.
    Kelly CG, Shattock RJ.
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [Abstract] [Full Text] [Related]

  • 5. [The acceptability on vaginal microbicides to prevent human immunodeficiency virus/sexually transmitted diseases].
    Han L, Wu ZL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):196-8. PubMed ID: 19565887
    [No Abstract] [Full Text] [Related]

  • 6. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
    Hart CW, Joanis C, Hartmann M, Milford C, Smit J, Beksinska M, Rambally-Greener L, Pienaar J, Mabude Z, Butterworth GAM, Sokal D, Jenkins D.
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
    [Abstract] [Full Text] [Related]

  • 7. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH, Kilmarx PH, Jones HE, Karon JM, Chaikummao S.
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [Abstract] [Full Text] [Related]

  • 8. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
    Mbopi-Keou FX, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere JF, Domingo MC, Piret J, Tsague L, Zekeng L, Mwatha A, Mâsse B, Bergeron MG.
    Contraception; 2009 Nov; 80(5):484-92. PubMed ID: 19835725
    [Abstract] [Full Text] [Related]

  • 10. Measurement of microbicide acceptability among U.S. adolescent girls.
    Short MB, Perfect MM, Auslander BA, Devellis RF, Rosenthal SL.
    Sex Transm Dis; 2007 Jun; 34(6):362-6. PubMed ID: 17038964
    [Abstract] [Full Text] [Related]

  • 11. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India.
    Joglekar NS, Joshi SN, Deshpande SS, Parkhe AN, Katti UR, Mehendale SM.
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):412-5. PubMed ID: 20096909
    [Abstract] [Full Text] [Related]

  • 12. A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel.
    Cohen JA, Brache V, Foster J, Cochon L, Callahan M, Schwartz J.
    Sex Transm Dis; 2013 Jun; 40(6):476-81. PubMed ID: 23677021
    [Abstract] [Full Text] [Related]

  • 13. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
    Olsen ML, Cwiak CA, Koudelka C, Jensen JT.
    Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444
    [Abstract] [Full Text] [Related]

  • 14. A Randomized Crossover Study Evaluating the Use and Acceptability of the SILCS Diaphragm Compared to Vaginal Applicators for Vaginal Gel Delivery.
    Beksinska M, Greener R, Smit J, Maphumulo B, Mphili N, Kilbourne-Brook M, Coffey PS.
    AIDS Behav; 2018 Jan; 22(1):127-132. PubMed ID: 28993940
    [Abstract] [Full Text] [Related]

  • 15. Couples' acceptability of the SILCS diaphragm for microbicide delivery.
    Frezieres RG, Walsh T, Kilbourne-Brook M, Coffey PS.
    Contraception; 2012 Jan; 85(1):99-107. PubMed ID: 22067809
    [Abstract] [Full Text] [Related]

  • 16. Microbicide preference among young women in California.
    Holt BY, Morwitz VG, Ngo L, Harrison PF, Whaley KJ, Pettifor A, Nguyen AH.
    J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
    [Abstract] [Full Text] [Related]

  • 17. The slow evolution of microbicides for STD/HIV prevention.
    Howes J, Bass M.
    J Gend Specif Med; 1999 Apr; 2(3):22-3. PubMed ID: 11252848
    [No Abstract] [Full Text] [Related]

  • 18. Microbicides: putting women in control.
    Forbes A.
    WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770
    [Abstract] [Full Text] [Related]

  • 19. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.
    Nel AM, Mitchnick LB, Risha P, Muungo LT, Norick PM.
    J Womens Health (Larchmt); 2011 Aug; 20(8):1207-14. PubMed ID: 21774672
    [Abstract] [Full Text] [Related]

  • 20. First real success for anti-HIV gel: a new start for HIV microbicides?
    Ariën KK, Vanham G.
    Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.